These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

183 related items for PubMed ID: 3830244

  • 1. Pharmacokinetics of ciprofloxacin tablets in renal failure; influence of haemodialysis.
    Singlas E, Taburet AM, Landru I, Albin H, Ryckelinck JP.
    Eur J Clin Pharmacol; 1987; 31(5):589-93. PubMed ID: 3830244
    [Abstract] [Full Text] [Related]

  • 2. Pharmacokinetics of ornidazole in patients with renal insufficiency; influence of haemodialysis and peritoneal dialysis.
    Merdjan H, Baumelou A, Diquet B, Chick O, Singlas E.
    Br J Clin Pharmacol; 1985 Feb; 19(2):211-7. PubMed ID: 3986079
    [Abstract] [Full Text] [Related]

  • 3. The pharmacokinetics of ciprofloxacin in patients with impaired renal function.
    Boelaert J, Valcke Y, Schurgers M, Daneels R, Rosseneu M, Rosseel MT, Bogaert MG.
    J Antimicrob Chemother; 1985 Jul; 16(1):87-93. PubMed ID: 2931415
    [Abstract] [Full Text] [Related]

  • 4. Disposition of fleroxacin, a new trifluoroquinolone, and its metabolites. Pharmacokinetics in renal failure and influence of haemodialysis.
    Singlas E, Leroy A, Sultan E, Godin M, Moulin B, Taburet AM, Dhib M, Fillastre JP.
    Clin Pharmacokinet; 1990 Jul; 19(1):67-79. PubMed ID: 2116256
    [Abstract] [Full Text] [Related]

  • 5. Pharmacokinetics of lamotrigine in patients with renal impairment: influence of haemodialysis.
    Fillastre JP, Taburet AM, Fialaire A, Etienne I, Bidault R, Singlas E.
    Drugs Exp Clin Res; 1993 Jul; 19(1):25-32. PubMed ID: 8223137
    [Abstract] [Full Text] [Related]

  • 6. Pharmacokinetics of cefepime in subjects with renal insufficiency.
    Barbhaiya RH, Knupp CA, Forgue ST, Matzke GR, Guay DR, Pittman KA.
    Clin Pharmacol Ther; 1990 Sep; 48(3):268-76. PubMed ID: 2401125
    [Abstract] [Full Text] [Related]

  • 7. Pharmacokinetics of ofloxacin in healthy subjects and patients with varying degrees of renal impairment.
    Flor S, Guay D, Opsahl J, Tack K, Matzke G.
    Int J Clin Pharmacol Res; 1991 Sep; 11(3):115-21. PubMed ID: 1809697
    [Abstract] [Full Text] [Related]

  • 8. Pharmacokinetics of atenolol in patients with terminal renal failure and influence of haemodialysis.
    Flouvat B, Decourt S, Aubert P, Potaux L, Domart M, Goupil A, Baglin A.
    Br J Clin Pharmacol; 1980 Apr; 9(4):379-85. PubMed ID: 7378254
    [Abstract] [Full Text] [Related]

  • 9. Pharmacokinetics of cefonicid in uraemic patients.
    Fillastre JP, Fourtillan JB, Leroy A, Ramis N, Lefevre MA, Reumont G, Humbert G.
    J Antimicrob Chemother; 1986 Aug; 18(2):203-11. PubMed ID: 3759731
    [Abstract] [Full Text] [Related]

  • 10. Pharmacokinetics of ofloxacin and adequacy of maintenance dose for patients on haemodialysis.
    Kampf D, Borner K, Pustelnik A.
    J Antimicrob Chemother; 1990 Nov; 26 Suppl D():61-8. PubMed ID: 2286592
    [Abstract] [Full Text] [Related]

  • 11. [Pharmacokinetics of azlocillin in chronic renal failure and hemodialysis patients].
    Fillastre JP, Humbert G, Leroy A, Godin M.
    Presse Med; 1984 Mar 29; 13(13):797-801. PubMed ID: 6231597
    [Abstract] [Full Text] [Related]

  • 12. Influence of haemodialysis on the pharmacokinetics of ciprofloxacin.
    Samsom JP.
    Pharm Weekbl Sci; 1987 Dec 11; 9 Suppl():S23-5. PubMed ID: 3438149
    [Abstract] [Full Text] [Related]

  • 13. Pharmacokinetics, safety, and tolerability of edoxaban in end-stage renal disease subjects undergoing haemodialysis.
    Parasrampuria DA, Marbury T, Matsushima N, Chen S, Wickremasingha PK, He L, Dishy V, Brown KS.
    Thromb Haemost; 2015 Apr 11; 113(4):719-27. PubMed ID: 25566930
    [Abstract] [Full Text] [Related]

  • 14. Pharmacokinetics of tinidazole in chronic renal failure and in patients on haemodialysis.
    Flouvat BL, Imbert C, Dubois DM, Temperville BP, Roux AF, Chevalier GC, Humbert G.
    Br J Clin Pharmacol; 1983 Jun 11; 15(6):735-41. PubMed ID: 6871072
    [Abstract] [Full Text] [Related]

  • 15. An assessment of the effects of impaired renal function and haemodialysis on the pharmacokinetics of fluconazole.
    Toon S, Ross CE, Gokal R, Rowland M.
    Br J Clin Pharmacol; 1990 Feb 11; 29(2):221-6. PubMed ID: 2306414
    [Abstract] [Full Text] [Related]

  • 16. Oral flecainide pharmacokinetics in patients with impaired renal function.
    Forland SC, Burgess E, Blair AD, Cutler RE, Kvam DC, Weeks CE, Fox JM, Conard GJ.
    J Clin Pharmacol; 1988 Mar 11; 28(3):259-67. PubMed ID: 3129455
    [Abstract] [Full Text] [Related]

  • 17. Pharmacokinetics of meropenem in subjects with renal insufficiency.
    Leroy A, Fillastre JP, Etienne I, Borsa-Lebás F, Humbert G.
    Eur J Clin Pharmacol; 1992 Mar 11; 42(5):535-8. PubMed ID: 1607000
    [Abstract] [Full Text] [Related]

  • 18. Ofloxacin pharmacokinetics in renal failure.
    Fillastre JP, Leroy A, Humbert G.
    Antimicrob Agents Chemother; 1987 Feb 11; 31(2):156-60. PubMed ID: 3471179
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Pharmacokinetics of intravenously administered ciprofloxacin in patients with various degrees of renal function.
    Drusano GL, Weir M, Forrest A, Plaisance K, Emm T, Standiford HC.
    Antimicrob Agents Chemother; 1987 Jun 11; 31(6):860-4. PubMed ID: 3619418
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.